These findings further indicated that overexpression of SNAI2 by human tumours could be of importance to both cell fate selection by genotoxic anticancer agents (Perez-Mancera et al, 2005) and clinical management of human cancer patients (Elloul et al, 2005; Shih et al, 2005; Bermejo-Rodriguez et al, 2006; Come et al, 2006). Here, SNAI2 is linked to neoplasm.